rs1420101
|
|
T |
0.710 |
GeneticVariation |
GWASCAT |
A loss-of-function variant in ALOX15 protects against nasal polyps and chronic rhinosinusitis.
|
30643255 |
2019 |
rs34210653
|
|
G |
0.710 |
GeneticVariation |
GWASCAT |
Most notably, a missense variant in ALOX15 that causes a p.Thr560Met alteration in arachidonate 15-lipoxygenase (15-LO) confers large genome-wide significant protection against NP (P = 8.0 × 10<sup>-27</sup>, odds ratio = 0.32; 95% confidence interval = 0.26, 0.39) and CRS (P = 1.1 × 10<sup>-8</sup>, odds ratio = 0.64; 95% confidence interval = 0.55, 0.75). p.Thr560Met, carried by around 1 in 20 Europeans, was previously shown to cause near total loss of 15-LO enzymatic activity.
|
30643255 |
2019 |
rs1050152
|
|
C |
0.700 |
GeneticVariation |
GWASCAT |
A loss-of-function variant in ALOX15 protects against nasal polyps and chronic rhinosinusitis.
|
30643255 |
2019 |
rs10905284
|
|
C |
0.700 |
GeneticVariation |
GWASCAT |
A loss-of-function variant in ALOX15 protects against nasal polyps and chronic rhinosinusitis.
|
30643255 |
2019 |
rs1391371
|
|
T |
0.700 |
GeneticVariation |
GWASCAT |
A loss-of-function variant in ALOX15 protects against nasal polyps and chronic rhinosinusitis.
|
30643255 |
2019 |
rs1444782
|
|
G |
0.700 |
GeneticVariation |
GWASCAT |
A loss-of-function variant in ALOX15 protects against nasal polyps and chronic rhinosinusitis.
|
30643255 |
2019 |
rs174535
|
|
T |
0.700 |
GeneticVariation |
GWASCAT |
A loss-of-function variant in ALOX15 protects against nasal polyps and chronic rhinosinusitis.
|
30643255 |
2019 |
rs17718444
|
|
C |
0.700 |
GeneticVariation |
GWASCAT |
A loss-of-function variant in ALOX15 protects against nasal polyps and chronic rhinosinusitis.
|
30643255 |
2019 |
rs1837253
|
|
C |
0.700 |
GeneticVariation |
GWASCAT |
A loss-of-function variant in ALOX15 protects against nasal polyps and chronic rhinosinusitis.
|
30643255 |
2019 |
rs1888909
|
|
T |
0.700 |
GeneticVariation |
GWASCAT |
A loss-of-function variant in ALOX15 protects against nasal polyps and chronic rhinosinusitis.
|
30643255 |
2019 |
rs2428494
|
|
A |
0.700 |
GeneticVariation |
GWASCAT |
A loss-of-function variant in ALOX15 protects against nasal polyps and chronic rhinosinusitis.
|
30643255 |
2019 |
rs28383314
|
|
C |
0.700 |
GeneticVariation |
GWASCAT |
A loss-of-function variant in ALOX15 protects against nasal polyps and chronic rhinosinusitis.
|
30643255 |
2019 |
rs338598
|
|
C |
0.700 |
GeneticVariation |
GWASCAT |
A loss-of-function variant in ALOX15 protects against nasal polyps and chronic rhinosinusitis.
|
30643255 |
2019 |
rs4807542
|
|
G |
0.700 |
GeneticVariation |
GWASCAT |
A loss-of-function variant in ALOX15 protects against nasal polyps and chronic rhinosinusitis.
|
30643255 |
2019 |
rs62408225
|
|
A |
0.700 |
GeneticVariation |
GWASCAT |
A loss-of-function variant in ALOX15 protects against nasal polyps and chronic rhinosinusitis.
|
30643255 |
2019 |
rs6543124
|
|
T |
0.700 |
GeneticVariation |
GWASCAT |
A loss-of-function variant in ALOX15 protects against nasal polyps and chronic rhinosinusitis.
|
30643255 |
2019 |
rs7302200
|
|
A |
0.700 |
GeneticVariation |
GWASCAT |
A loss-of-function variant in ALOX15 protects against nasal polyps and chronic rhinosinusitis.
|
30643255 |
2019 |
rs8046011
|
|
G |
0.700 |
GeneticVariation |
GWASCAT |
A loss-of-function variant in ALOX15 protects against nasal polyps and chronic rhinosinusitis.
|
30643255 |
2019 |